A new way of selecting atrial electrograms for ablatio

Not Applicable

Recruiting

• Conditions: Atrial fibrillation; Cardiovascular - Other cardiovascular diseases

• Registration Number: ACTRN12612001224819
• Lead Sponsor: Prof Prash Sanders, Dr Anand Ganesan

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-11-20
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

The study population will be patients undergoing curative catheter ablation for atrial fibrillation defined according to the HRS/ACC consensus statement at Royal Adelaide Hospital. The planned recruitment is 20patients over a study period of 18 months.

Exclusion Criteria

The following exclusion criteria will apply: (i) age <18 years; (ii) pregnancy (iii) left atrial appendage thrombus on transoesophageal echocardiography (iv)previous AF ablation.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in AF cycle length, by measurement of cycle length on intracardiac electrogram.[Intraprocedural];Change to atrial tachycardia, by assessment of intracardiac electrograms.[Intraprocedural];Termination of AF, by assessment of intracardiac electrograms[Intraprocedural]

Secondary Outcome Measures

Name	Time	Method
eed for anti-arrhythmic drugs. This will be assessed at clinical follow-up by treating physician by chart review.[6-week, 3-months, 6-months, 9-months, 12-months.];requirement for hospitalisation. This will be assessed at clinical follow-up and patient hospital record retrieval.[6-week, 3-months, 6-months, 9-months, 12-months.];need for repeat procedures. This will be assessed by chart review.[6-week, 3-months, 6-months, 9-months, 12-months.];symptomatic AF/atrial tachyarrhythmia, by clinical review and Holter-monitor.[6-week, 3-months, 6-months, 9-months, 12-months.]